Racemose neurocysticercosis: Neuroimaging guides the diagnosis

Carlos Hugo Zapata, Sergio Alberto Vargas, Carlos Santiago Uribe, .

Keywords: Neurocysticercosis/diagnosis, arachnoiditis, Western blot, neuroimaging, Taenia solium, prognosis.

Abstract

Neurocysticercosis is the leading cause of parasitosis of the central nervous system and acquired epilepsy in developing countries. The clinical manifestations of neurocysticercosis, especially its racemose variant, are pleomorphic and unspecific, characteristics that hinder the diagnosis and make it a challenge for the clinician.
The objective of this report was to describe two cases of racemose neurocysticercosis in which neuroimaging led to the definitive diagnosis. The first case involved a patient with persistent headache and focal neurological signs. She required multiple paraclinical tests that led to the definitive diagnosis of racemose neurocysticercosis with secondary cerebral vasculitis. Despite medical and surgical treatment the patient died after multiple complications.
The second case involved a patient with a history of neurocysticercosis, who consulted for chronic intractable vomiting. She required multiple paraclinical tests that led to the diagnosis of vomiting of central origin secondary to racemose neurocysticercosis and entrapment of the fourth ventricle. After medical and surgical treatment the patient showed slight improvement.
In these two cases it was evident how proper interpretation of neuroimages is essential for the diagnosis of racemose neurocysticercosis.

Downloads

Download data is not yet available.
  • Carlos Hugo Zapata Sección de Neurología, Departamento de Medicina Interna, Hospital Universitario de San Vicente Fundación, Universidad de Antioquia, Medellín, Colombia
  • Sergio Alberto Vargas Sección de Neurorradiología, Departamento de Radiología, Hospital Universitario de San Vicente Fundación, Universidad de Antioquia, Medellín, Colombia
  • Carlos Santiago Uribe Sección de Neurología, Departamento de Medicina Interna, Hospital Universitario de San Vicente Fundación, Universidad de Antioquia, Medellín, Colombia

References

Del Brutto OH. Neurocysticercosis: A review. Scientific World Journal. 2012;2012:159821. http://dx.doi.org/10.1100/2012/159821

Singh G, Burneo JG, Sander JW. From seizures to epilepsy and its substrates: Neurocysticercosis. Epilepsia. 2013;54:783-92. http://dx.doi.org/10.1111/epi.12159

Hawk M, Shahlaie K, Kim K, Theis J. Neurocysticercosis: A review. Surg Neurol. 2005;63:123-32. http://dx.doi.org/10.1016/j.surneu.2004.02.033

Fabiani S, Bruschi F. Neurocysticercosis in Europe: Still a public health concern not only for imported cases. Acta Trop. 2013;128:18-26. http://dx.doi.org/10.1016/j.actatropica.2013.06.020

Del Brutto OH. Neurocysticercosis. Handb Clin Neurol. 2014;121:1445-59. http://dx.doi.org/10.1016/B978-0-7020-4088-7.00097-3

Del Brutto OH. Neurocysticercosis. Continuum (Minneap Minn). 2012;18:1392-416. http://dx.doi.org/10.1212/01.CON.0000423853.47770.90

Flisser A. Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol. 1994;4:77-116. http://dx.doi.org/10.1186/1756-3305-5-18

Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis.Parasitol Int. 2006;55(Suppl.):S111-5. http://dx.doi.org/10.1016/j.parint.2005.11.016

Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: A systematic review. PLoS Negl

Trop Dis. 2011;5:e1152. http://dx.doi.org/10.1371/journal.pntd.0001152

Mahale R, Mehta A, Rangasetty S. Extraparenchymal (racemose) neurocysticercosis and its multitude manifestations: A comprehensive review. J Clin Neurol. 2015;11:203-11. http://dx.doi.org/10.3988/jcn.2015.11.3.203

Sarria S, Frascheri L, Siurana S, Auger C, Rovira A. Imaging findings in neurocysticercosis. Radiología. 2013;55:130-41. http://dx.doi.org/10.1016/j.rxeng.2011.11.003

Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host

and environmental factors. Trans R Soc Trop Med Hyg.2010;104:243-50. http://dx.doi.org/10.1016/j.trstmh.2010.01.005

Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57:177-83.

http://dx.doi.org/10.1212/WNL.57.2.177

Zhao JL, Lerner A, Shu Z GX. Imaging spectrum of neurocysticercosis. Radiol Infect Dis. 2015;1:94-102. http://dx.doi.org/10.1016/j.jrid.2014.12.001

Zee CS, Go JL, Kim PE DC. Imaging of neurocysticercosis. Neuroimaging Clin N Am. 2000;10:391-407. http://dx.doi.org/10.1016/j.nic.2012.05.004

Lerner A, Shiroishi MS, Zee CS, Law M, Go JL. Imaging of neurocysticercosis. Neuroimaging Clin N Am. 2012;2:659-76. http://dx.doi.org/10.1016/j.nic.2012.05.004

Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chávez-Macías L PA, Quiroz-Rojas LY, et al. Neurocysticercosis: Radiologic-pathologic correlation. Radiographics. 2010;30:1705-19. http://dx.doi.org/10.1148/rg.306105522

Shandera WX, White AC, Chen JC, Díaz P, Armstrong R. Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore). 1994;73:37-52.

Barinagarrementeria F, Cantú C. Frequency of cerebral arteritis in subarachnoid cysticercosis: An angiographic study. Stroke. 1998;29:123-5. http://dx.doi.org/10.1161/01.STR.29.1.123

Góngora-Rivera F, Soto-Hernández JL, González D, Cook HJ, Márquez-Caraveo C, Hernández R, et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and

intraventricular cysticercosis. Neurology. 2006;66:436-8. http://dx.doi.org/10.1212/01.wnl.0000195887.63124.dc

Mitre E, Talaat KR, Sperling MR, Nash NT. Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis. Clin Infect Dis. 2007;44:549-53. http://dx.doi.org/10.1086/511040

Torres-Corzo JG, Tapia-Pérez JH, Rodríguez-Della Vecchia RR, Chalita-Williams JC, Sánchez-Aguilar M, Sánchez-Rodríguez JJ. Endoscopic management of hydrocephalus

due to neurocysticercosis. Clin Neurol Neurosurg. 2010;112:11-6. http://dx.doi.org/10.1016/j.clineuro.2009.08.022

Husain M, Jha DK, Rastogi M, Husain N, Gupta RK. Neuro-endoscopic management of intraventricular neurocysticercosis (NCC). Acta Neurochir (Wien). 2007;149:341-6.

http://dx.doi.org/10.1007/s00701-006-1059-z

Torres-Corzo J, Rodríguez-Della Vecchia R, Rangel-Castilla L. Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy. J

Neurosurg. 2006;104:746-8. http://dx.doi.org/10.3171/jns.2006.104.5.746

García HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev.

;15:747-56. http://dx.doi.org/10.1128/CMR.15.4.747-756.2002

Proaño JV, Torres-Corzo J, Rodríguez-Della Vecchia R, Guizar-Sahagun G, Rangel-Castilla L. Intraventricular and subarachnoid basal cisterns neurocysticercosis: A

comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst. 2009;25:1467-75. http://dx.doi.org/10.1007/s00381-009-0933-4

Sotelo J, Marín C. Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg. 1987;66:686-9. http://dx.doi.org/10.3171/jns.1987.66.5.0686

Matushita H, Pinto FC, Cardeal DD, Teixeira MJ. Hydrocephalus in neurocysticercosis. Childs Nerv Syst. 2011;27:1709-21. http://dx.doi.org/10.1007/s00381-011-1500-3

How to Cite
1.
Zapata CH, Vargas SA, Uribe CS. Racemose neurocysticercosis: Neuroimaging guides the diagnosis. biomedica [Internet]. 2017 Apr. 1 [cited 2024 May 17];37(Sup.1):26-32. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/2983
Published
2017-04-01

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code